For the millions of family members managing dementia at home, the gap between evidence-based behavioral strategies and practical access to them has long been a critical failure point in care. A structured digital tool that bridges this gap could meaningfully reduce one of dementia's most burdensome dimensions — not for patients alone, but for the caregivers whose own health often deteriorates alongside the people they support.
This prospective randomized trial enrolled 262 community-dwelling dementia caregivers, assigning 131 to immediate use of the WeCareAdvisor web application and 131 to a delayed-access control group. The app operationalizes the DICE framework — Describe, Investigate, Create, Evaluate — guiding caregivers through structured behavioral assessment to generate tailored, nonpharmacological management strategies termed "Prescriptions." At the three-month primary endpoint, immediate users showed measurable improvements across caregiver distress, confidence in managing behavioral symptoms, and composite behavioral frequency-severity scores relative to controls. Seven pre-specified secondary outcomes, including caregiver wellbeing and functional dependence metrics, were also tracked, providing a multidimensional picture of the intervention's reach.
This study carries weight for several reasons. The DICE approach has prior empirical grounding as a clinical decision-making model, but its translation into a self-administered digital format for lay caregivers represents a meaningful scalability advance. The randomized design with masked interviewers addresses a key methodological weakness common in behavioral intervention research. That said, the sample skewed heavily White (83%) and college-educated (93%), limiting generalizability to more diverse caregiver populations who arguably bear a disproportionate burden of informal dementia care. The relatively short three-month horizon also leaves open whether benefits persist or decay without ongoing engagement. Still, as pharmacological options for dementia-related behavioral symptoms remain limited and often carry significant adverse effects, a scalable, low-cost digital nonpharmacological tool with RCT support is a substantively important addition to the caregiver toolkit.